Table 2.

Prospective trials evaluated allogeneic stem cell transplantation as part of the first line treatment of MM

YEAR	Design	Novel agents used	Results favoring allo
Bruno B et al, 2007 NEJM [131]	Auto-Auto vs Auto- Allo	no	Yes
Krishan et al, 2011 Lancet Oncology [132]	Auto-Auto vs. Auto-	Thal maintainance	No
Lokhorst 2012 Blood [133]	Allo Auto-Auto vs Auto Allo	Thal induction	No
Garban et al, 2006 Blood [127]	Auto-Auto vs. Auto- allo	no	No
Bjorkstrand B et al 2011 JCO [129] Updated by Gahrton et al., 2013 Blood [150]	Auto-Auto vs Auto- Allo	no	Yes
Rosinol L et al, 2008 Blood [128]	Auto-auto vs auto- allo	no	No
Knop, S ASH 2014 [130]	Auto-auto vs auto- allo in del13q	no	Yes